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There was an omission of the first paragraph in the Methods section that
was supported by one extra reference, hence the numbers in the reference list 
and the superscripted numbers, n, in the text, following reference 14, should now 
read n+1.
The paragraph is the following:
Design of the study
This study was planned to evaluate the effect of reimbursement status on smoking 
cessation interventions, retrospectively, by using a study population, that applied 
at the free smoking-cessation medication distribution period, comprising groups 
that obtained the smoking cessation medications out of their own pocket. The 
free smoking-cessation medications distributed group’s treatment adherence 
and quit success status were previously studied and published14. For this current 
study that group was used as a control group for evaluating a new research 
question. Ethical approval was obtained from the local ethics committee 
(number:78646441-050.01.04-date:19.04.2018), and permission for the study 
was also obtained from the General Secretary of the hospital.
The additional reference is:
14. Karadoğan D, Önal O, Say Şahin D, Kanbay Y, Alp S, Şahin U. Treatment 
adherence and short-term outcomes of smoking cessation outpatient clinic 
patients. Tob Induc Dis. 2018;16(August). doi:10.18332/tid/94212
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